路易体痴呆的时空动态演化:基于代谢PET成像的研究
本研究回顾性纳入123名参与者(31名健康对照和92名路易体痴呆患者)的18F-FDG PET数据,采用基于18F-FDG PET的亚型与分期推断(SuStaIn)模型,揭示路易体痴呆存在分别起源于新皮质和基底节区的两种神经退行性演化模式(亚型1和亚型2)。亚型2男性比例更高(P=0.045),视幻觉(P=0.033)和认知波动(P=0.033)等阳性症状更常见,认知损害、代谢异常、多巴胺能功能障碍及进展均更严重(均P<0.05),且SuStaIn亚型与帕金森病痴呆和路易体痴呆两种临床表型相关(P=0.005)。
要点
- 基于18F-FDG PET的SuStaIn模型在路易体痴呆中识别出分别起源于新皮质和基底节区的两种演化亚型。
- 亚型2男性比例更高(P=0.045),视幻觉(P=0.033)和认知波动(P=0.033)更常见。
- 亚型2的认知损害、代谢异常、多巴胺能功能障碍及进展均更严重(均P<0.05),且亚型与临床表型相关(P=0.005)。
核心结论
- 基于18F-FDG PET和数据驱动模型揭示了路易体痴呆的时空动态演化,并在活体内分类出具有不同演化模式、临床和影像特征的新亚型。
- 演化相关亚型与路易体痴呆临床表型相关,支持路易体痴呆谱系中存在不同实体的观点。
研究设计与样本
- 回顾性纳入123名参与者(31名健康对照和92名路易体痴呆患者),均接受18F-FDG PET扫描。
- 建立基于18F-FDG PET的亚型与分期推断(SuStaIn)模型,以阐明时空演化模式并分类相关亚型。
- 将亚型与分期进一步与路易体痴呆患者的临床特征、葡萄糖代谢和多巴胺能功能相关联。
主要发现
- 基于18F-FDG PET的方法揭示了路易体痴呆中分别起源于新皮质和基底节区的两种不同神经退行性演化模式,定义为亚型1和亚型2。
- 与亚型1相比,亚型2男性患者比例更大(P=0.045),视幻觉(P=0.033)和认知波动(P=0.033)等阳性症状更常见。
- 亚型2的认知损害、代谢异常、多巴胺能功能障碍和进展均更严重(均P<0.05)。
- SuStaIn亚型与两种临床表型(帕金森病痴呆和路易体痴呆)之间存在强关联(P=0.005)。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
PURPOSE: Lewy body dementia (LBD) is a neurodegenerative disease with high heterogeneity and complex pathogenesis. Our study aimed to use disease progression modeling to uncover spatial-temporal dynamic evolution of LBD in vivo, and to explore differential profiles of clinical features, glucose metabolism, and dopaminergic function among different evolution-related subtypes. METHODS: A total of 123 participants (31 healthy controls and 92 LBD patients) who underwent 18F-FDG PET scans were retrospectively enrolled. 18F-FDG PET-based Subtype and Stage Inference (SuStaIn) model was established to illustrate spatial-temporal evolutionary patterns and categorize relevant subtypes. Then subtypes and stages were further related to clinical features, glucose metabolism, and dopaminergic function of LBD patients. RESULTS: This 18F-FDG PET imaging-based approach illustrated two distinct patterns of neurodegenerative evolution originating from the neocortex and basal ganglia in LBD and defined them as subtype 1 and subtype 2, respectively. There were obvious differences between subtypes. Compared with subtype 1, subtype 2 exhibited a greater proportion of male patients (P = 0.045) and positive symptoms such as visual hallucinations (P = 0.033) and fluctuating cognitions (P = 0.033). Cognitive impairment, metabolic abnormalities, dopaminergic dysfunction and progression were all more severe in subtype 2 (all P < 0.05). In addition, a strong association was observed between SuStaIn subtypes and two clinical phenotypes (Parkinson's disease dementia and dementia with Lewy bodies) (P = 0.005). CONCLUSIONS: Our findings based on 18F-FDG PET and data-driven model illustrated spatial-temporal dynamic evolution of LBD and categorized novel subtypes with different evolutionary patterns, clinical and imaging features in vivo. The evolution-related subtypes are associated with LBD clinical phenotypes, which supports the perspective of existence of distinct entities in LBD spectrum.
引用
- Niu J, Zhong Y, Xue L, et al. Spatial-temporal dynamic evolution of lewy body dementia by metabolic PET imaging. Eur J Nucl Med Mol Imaging. 2024. PMID: 39155308. doi:10.1007/s00259-024-06881-w
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。